Patienter med selvmordsforsøg i anamnesen, og de der udviser en høj grad af selvmordstanker før start af behandling, vides at have større risiko for at få selvmordstanker og forsøg på selvmord, og bør derfor monitoreres meget nøje under behandlingen.
Patients with a history of suicide-related events or those exhibiting a significant degree of suicidal ideation prior to commencement of treatment are known to be at greater risk of suicidal thoughts or suicide attempts, and should receive careful monitoring during treatment.